Clinical Study
Impact on the Quality of Erections after Completing a Low-Intensity Extracorporeal Shock Wave Treatment Cycle on a Group of 710 Patients
Table 1
Baseline characteristics of the study group.
| Variable | Value, median (range)/frequency (percent) |
| Age (years) | 58 (24–83) | Baseline EHS | 0 | 95 (13.4) | 1 | 143 (20.1) | 2 | 282 (39.7) | 3 | 190 (26.8) | Smokers | 266 (37.5) | Patients in an established relationship | 495 (69.7) | Previous treatment | 430 (60.6) | Duration of dysfunction (years) | 3.9 (0–50) | Medical history (relevant diagnosis to ED) | Diabetes I | 16 (2.3) | Diabetes II | 140 (19.7) | Dyslipidemia | 233 (32.8) | Hypertension | 228 (32.1) | Hypertriglyceridemia | 44 (6.2) | Acute myocardial infarction | 19 (2.7) | Malignant prostate disease (in remission) | 3 (0.4) | Prostatitis | 7 (1) | Benign tumour of the prostate | 35 (4.9) | Kidney transplant | 2 (0.3) | Sexually transmitted diseases | 4 (0.5) | Cerebrovascular accident | 6 (0.8) | Peyronie’s disease | 7 (1) | HIV infection | 4 (0.6) | Heart surgery | 24 (3.4) | Vascular surgery | 31 (4.4) | Prostate surgery | 21 (3) | Circumcision | 100 (14.1) | Testicular surgery | 23 (3.2) | Vasectomy | 79 (11.1) | Spinal surgery | 17 (2.4) |
|
|
HIV: human immunodeficiency virus; continuous variables are expressed as median (range) and categorical variables as frequency (percentage).
|